153 related articles for article (PubMed ID: 27637481)
21. Report on stage III Pig-a mutation assays using benzo[a]pyrene.
Bhalli JA; Shaddock JG; Pearce MG; Dobrovolsky VN; Cao X; Heflich RH; Vohr HW
Environ Mol Mutagen; 2011 Dec; 52(9):731-7. PubMed ID: 22052432
[TBL] [Abstract][Full Text] [Related]
22. The mutagenic activity of ethylmethanesulphonate, benzidine and benzo[a]pyrene at the hprt locus of wild-type L5178Y mouse lymphoma cells.
Kennelly JC; Clare CB; Campbell J; Lane MP; Harrington DH; Cole H; Garner RC
Mutagenesis; 1990; 5 Suppl():21-6. PubMed ID: 2184316
[TBL] [Abstract][Full Text] [Related]
23. Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells.
Mersch-Sundermann V; Schneider H; Freywald C; Jenter C; Parzefall W; Knasmüller S
Mutat Res; 2001 Aug; 495(1-2):89-96. PubMed ID: 11448646
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
[TBL] [Abstract][Full Text] [Related]
25. Sustained induction of cytochrome P4501A1 in human hepatoma cells by co-exposure to benzo[a]pyrene and 7H-dibenzo[c,g]carbazole underlies the synergistic effects on DNA adduct formation.
Gábelová A; Poláková V; Prochazka G; Kretová M; Poloncová K; Regendová E; Luciaková K; Segerbäck D
Toxicol Appl Pharmacol; 2013 Aug; 271(1):1-12. PubMed ID: 23639521
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
27. Vinclozolin, a widely used fungizide, enhanced BaP-induced micronucleus formation in human derived hepatoma cells by increasing CYP1A1 expression.
Wu XJ; Lu WQ; Roos PH; Mersch-Sundermann V
Toxicol Lett; 2005 Oct; 159(1):83-8. PubMed ID: 15979257
[TBL] [Abstract][Full Text] [Related]
28. Induction of mutations in TK6 human lymphoblastoid cells by ethyl methanesulphonate, benzo[a]pyrene and benzidine.
O'Brien KA; Gatehouse DG; Tiley M
Mutagenesis; 1990; 5 Suppl():55-60. PubMed ID: 2184322
[TBL] [Abstract][Full Text] [Related]
29. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing.
Crespi CL; Gonzalez FJ; Steimel DT; Turner TR; Gelboin HV; Penman BW; Langenbach R
Chem Res Toxicol; 1991; 4(5):566-72. PubMed ID: 1793807
[TBL] [Abstract][Full Text] [Related]
30. Determination of Mutational Spectra Induced by Environmental Toxicants in Complex Human Cell Populations.
Gealy R; Keohavong P
Methods Mol Biol; 2020; 2102():303-314. PubMed ID: 31989563
[TBL] [Abstract][Full Text] [Related]
31. Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase.
Crofton-Sleigh C; Doherty A; Ellard S; Parry EM; Venitt S
Mutagenesis; 1993 Jul; 8(4):363-72. PubMed ID: 8377657
[TBL] [Abstract][Full Text] [Related]
32. The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency.
Brüsehafer K; Manshian BB; Doherty AT; Zaïr ZM; Johnson GE; Doak SH; Jenkins GJ
Mutagenesis; 2016 Mar; 31(2):171-80. PubMed ID: 26362870
[TBL] [Abstract][Full Text] [Related]
33. Mutation assays of ethyl methanesulphonate, benzidine and benzo[a]pyrene using Chinese hamster V79 cells.
O'Donovan MR
Mutagenesis; 1990; 5 Suppl():9-13. PubMed ID: 2184328
[TBL] [Abstract][Full Text] [Related]
34. Development of an integrated assay in human TK6 cells to permit comprehensive genotoxicity analysis in vitro.
Smart DJ; Helbling FR; Verardo M; Huber A; McHugh D; Vanscheeuwijck P
Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503129. PubMed ID: 32087850
[TBL] [Abstract][Full Text] [Related]
35. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
36. Effect of chrysin, a flavonoid compound, on the mutagenic activity of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) and benzo(a)pyrene (B(a)P) in bacterial and human hepatoma (HepG2) cells.
Uhl M; Ecker S; Kassie F; Lhoste E; Chakraborty A; Mohn G; Knasmüller S
Arch Toxicol; 2003 Aug; 77(8):477-84. PubMed ID: 12856103
[TBL] [Abstract][Full Text] [Related]
37. Genotoxicity of 1-methylpyrene and 1-hydroxymethylpyrene in Chinese hamster V79-derived cells expressing both human CYP2E1 and SULT1A1.
Jiang H; Lai Y; Hu K; Chen D; Liu B; Liu Y
Environ Mol Mutagen; 2015 May; 56(4):404-11. PubMed ID: 25243916
[TBL] [Abstract][Full Text] [Related]
38. A co-culture system of human intestinal Caco-2 cells and lymphoblastoid TK6 cells for investigating the genotoxicity of oral compounds.
Le Hégarat L; Huet S; Fessard V
Mutagenesis; 2012 Nov; 27(6):631-6. PubMed ID: 22844081
[TBL] [Abstract][Full Text] [Related]
39. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
40. Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity.
Maier A; Schumann BL; Chang X; Talaska G; Puga A
Mutat Res; 2002 May; 517(1-2):101-11. PubMed ID: 12034312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
